drugset / Trial / NCT00377806

Topical Diclofenac Gel in Patients With Superficial Inflammation of the Veins

NCT00377806

Phase 4 Completed 200 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the efficacy, safety and tolerability of topically administered diclofenac gel versus placebo with respect to the symptom score (pain, temperature and size of erythema along the superficial vein)

Timeline

Start
2003-01
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified Topical

Indications